Invesco
KYTX icon

Invesco’s Kyverna Therapeutics KYTX Stock Holding History

Invesco’s Portfolio KYTX Stock Details KYTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$497K Sell
55,807
-130,867
-70% -$1.16M ﹤0.01% 3237
2026
Q1 		$1.61M Buy
+186,674
New +$1.56M ﹤0.01% 2646
2024
Q2 		– Sell
-75,865
Closed -$1.88M – 3986
2024
Q1 		$1.88M Buy
+75,865
New +$2.12M ﹤0.01% 2699

Other funds holding KYTX

GGI
GordonMD Global Investments Beverely Hills, California $207M AUM
GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IHG
Insight Holdings Group New York $1.32B AUM 1.62% 1-Year Est. Return

Invesco's KYTX Position: Q2 2026 in Review

Invesco reduced its Kyverna Therapeutics (KYTX) stake by 70% in Q2 2026, selling an estimated $1.16M and leaving 55,807 shares worth $497K. The position accounts for ﹤0.01% of the portfolio, ranked #3237.

Invesco first reported a position in KYTX in Q1 2024 and has held it in 3 quarters since. The position peaked at $1.88M in Q1 2024. 121 funds tracked by Wall St. Rank hold KYTX as of Q2 2026.

  • Invesco held 55,807 shares of Kyverna Therapeutics worth $497K as of Q2 2026.
  • Invesco sold 130,867 Kyverna Therapeutics shares in Q2 2026, an estimated $1.16M.
  • Kyverna Therapeutics made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #3237 holding.
  • Invesco first reported a position in Kyverna Therapeutics in Q1 2024 and has held it in 3 quarters since.
  • Invesco's Kyverna Therapeutics position peaked at $1.88M in Q1 2024.
  • 121 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.